Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Plasma Fractionation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global plasma fractionation market size reached US$ 22.37 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 33.11 Billion by 2027, exhibiting a growth rate (CAGR) of 6.30% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Plasma fractionation refers to the downstream processing of donated plasma into life-saving therapies and medicinal products. It breaks plasma into individual proteins or plasma fractions using mechanical separation methods, such as centrifugation, depth filtration, precipitation, and chromatography. Nowadays, several modern fractionation processes use alcohol concentrations, time, temperature, and pH to extract specific therapeutic proteins. Moreover, increasing technology complexity over the years and the introduction of in-process viral reduction treatments have resulted in the development of new protein therapeutics and improvement in product purity and quality.

Plasma Fractionation Market Trends:

Protein products fractionated from human plasma are an essential class of therapeutics widely used to prevent, manage, and treat life-threatening conditions, such as infections, congenital deficiencies, rare blood disorders, immunologic disorders, and autoimmune disorders. A significant rise in the prevalence of these conditions among a significant part of the population globally represents one of the key factors impelling the market growth. In addition, manufacturers are developing plasma fractionation with additional safety features due to the implementation of stringent regulations and standard controls and settings by governing agencies of numerous countries on quality assurance of biological products. Apart from this, market players are financing research and development (R&D) activities to launch advancement in plasma production technology to improve product efficacy and enhance recovery of immunoglobulin G (IgG) to isolate new plasma proteins. Furthermore, they are focusing on developing affordable viral inactivation and processing technologies that allow utilization of local plasma resources safely. This, in confluence with the escalating need to improve yield, maintain process economics, and manage increasing regulatory requirements, is anticipated to provide a favorable market outlook in the coming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global plasma fractionation market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, sector, application and end user.

Breakup by Product:

  • Immunoglobulins
  • Albumin
  • Coagulation factor VIII
  • Coagulation factor IX
     

Breakup by Sector:

  • Private Sector
  • Public Sector
     

Breakup by Application:

  • Neurology
  • Immunology
  • Hematology
  • Other Applications
     

Breakup by End User:

  • Hospitals and Clinics
  • Clinical Research Laboratories
  • Academic Institutes
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being ADMA Biologics, Bio Products Laboratory Ltd., Boccard, Grifols, S.A., Hemarus Therapeutics Limited, Intas Pharmaceuticals Limited, LFB S.A., Merck Group, Octapharma AG, PlasmaGen BioSciences Pvt. Ltd., SK Plasma Co. Ltd. and Virchow Biotech Private Limited.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
    Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Product, Sector, Application, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered ADMA Biologics, Bio Products Laboratory Ltd., Boccard, Grifols, S.A., Hemarus Therapeutics Limited, Intas Pharmaceuticals Limited, LFB S.A., Merck Group, Octapharma AG, PlasmaGen BioSciences Pvt. Ltd., SK Plasma Co. Ltd. and Virchow Biotech Private Limited.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global plasma fractionation market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global plasma fractionation market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the sector?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global plasma fractionation market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Plasma Fractionation Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Product
    6.1    Immunoglobulins
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Albumin
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Coagulation factor VIII
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Coagulation factor IX
        6.4.1 Market Trends
        6.4.2 Market Forecast
7    Market Breakup by Sector
    7.1    Private Sector
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Public Sector
        7.2.1 Market Trends
        7.2.2 Market Forecast
8    Market Breakup by Application
    8.1    Neurology
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Immunology
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Hematology
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Other Applications
        8.4.1 Market Trends
        8.4.2 Market Forecast
9    Market Breakup by End User
    9.1    Hospitals and Clinics
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Clinical Research Laboratories
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Academic Institutes
        9.3.1 Market Trends
        9.3.2 Market Forecast
10    Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia-Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11    SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12    Value Chain Analysis
13    Porters Five Forces Analysis

    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14    Price Analysis
15    Competitive Landscape

    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    ADMA Biologics
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio
           15.3.1.3 Financials
        15.3.2    Bio Products Laboratory Ltd.
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio
        15.3.3    Boccard
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio
        15.3.4    Grifols, S.A.
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio
           15.3.4.3 Financials
           15.3.4.4 SWOT Analysis
        15.3.5    Hemarus Therapeutics Limited
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio
        15.3.6    Intas Pharmaceuticals Limited
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio
        15.3.7    LFB S.A.
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio
        15.3.8    Merck Group
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio
           15.3.8.3 Financials
           15.3.8.4 SWOT Analysis
        15.3.9    Octapharma AG
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio
           15.3.9.3 SWOT Analysis
        15.3.10    PlasmaGen BioSciences Pvt. Ltd.
           15.3.10.1 Company Overview
           15.3.10.2 Product Portfolio
        15.3.11    SK Plasma Co. Ltd.
           15.3.11.1 Company Overview
           15.3.11.2 Product Portfolio
        15.3.12    Virchow Biotech Private Limited
           15.3.12.1 Company Overview
           15.3.12.2 Product Portfolio

List of Figures

Figure 1: Global: Plasma Fractionation Market: Major Drivers and Challenges
Figure 2: Global: Plasma Fractionation Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Plasma Fractionation Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Plasma Fractionation Market: Breakup by Product (in %), 2021
Figure 5: Global: Plasma Fractionation Market: Breakup by Sector (in %), 2021
Figure 6: Global: Plasma Fractionation Market: Breakup by Application (in %), 2021
Figure 7: Global: Plasma Fractionation Market: Breakup by End User (in %), 2021
Figure 8: Global: Plasma Fractionation Market: Breakup by Region (in %), 2021
Figure 9: Global: Plasma Fractionation (Immunoglobulins) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Plasma Fractionation (Immunoglobulins) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Plasma Fractionation (Albumin) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Plasma Fractionation (Albumin) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Plasma Fractionation (Coagulation factor VIII) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Plasma Fractionation (Coagulation factor VIII) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Plasma Fractionation (Coagulation factor IX) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Plasma Fractionation (Coagulation factor IX) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Plasma Fractionation (Private Sector) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Plasma Fractionation (Private Sector) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Plasma Fractionation (Public Sector) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Plasma Fractionation (Public Sector) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Plasma Fractionation (Neurology) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Plasma Fractionation (Neurology) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Plasma Fractionation (Immunology) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Plasma Fractionation (Immunology) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Plasma Fractionation (Hematology) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Plasma Fractionation (Hematology) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Plasma Fractionation (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Plasma Fractionation (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Plasma Fractionation (Hospitals and Clinics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Plasma Fractionation (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Global: Plasma Fractionation (Clinical Research Laboratories) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Global: Plasma Fractionation (Clinical Research Laboratories) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Global: Plasma Fractionation (Academic Institutes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Global: Plasma Fractionation (Academic Institutes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: North America: Plasma Fractionation Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: North America: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: United States: Plasma Fractionation Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: United States: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Canada: Plasma Fractionation Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Canada: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Asia-Pacific: Plasma Fractionation Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Asia-Pacific: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: China: Plasma Fractionation Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: China: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: Japan: Plasma Fractionation Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: Japan: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: India: Plasma Fractionation Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: India: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: South Korea: Plasma Fractionation Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: South Korea: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: Australia: Plasma Fractionation Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: Australia: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Indonesia: Plasma Fractionation Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Indonesia: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: Others: Plasma Fractionation Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: Others: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: Europe: Plasma Fractionation Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: Europe: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Germany: Plasma Fractionation Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Germany: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: France: Plasma Fractionation Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: France: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: United Kingdom: Plasma Fractionation Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: United Kingdom: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Italy: Plasma Fractionation Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Italy: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: Spain: Plasma Fractionation Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: Spain: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: Russia: Plasma Fractionation Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: Russia: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Others: Plasma Fractionation Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Others: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Latin America: Plasma Fractionation Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Latin America: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Brazil: Plasma Fractionation Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Brazil: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Mexico: Plasma Fractionation Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Mexico: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Others: Plasma Fractionation Market: Sales Value (in Million US$), 2016 & 2021
Figure 80: Others: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: Middle East and Africa: Plasma Fractionation Market: Sales Value (in Million US$), 2016 & 2021
Figure 82: Middle East and Africa: Plasma Fractionation Market: Breakup by Country (in %), 2021
Figure 83: Middle East and Africa: Plasma Fractionation Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 84: Global: Plasma Fractionation Industry: SWOT Analysis
Figure 85: Global: Plasma Fractionation Industry: Value Chain Analysis
Figure 86: Global: Plasma Fractionation Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Plasma Fractionation Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Plasma Fractionation Market Forecast: Breakup by Product (in Million US$), 2022-2027
Table 3: Global: Plasma Fractionation Market Forecast: Breakup by Sector (in Million US$), 2022-2027
Table 4: Global: Plasma Fractionation Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 5: Global: Plasma Fractionation Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 6: Global: Plasma Fractionation Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 7: Global: Plasma Fractionation Market: Competitive Structure
Table 8: Global: Plasma Fractionation Market: Key Players


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links